Suppr超能文献

卵巢子宫内膜异位症对接受 IVF/ICSI 治疗的女性的卵子质量和数量有负面影响,但对妊娠结局没有影响:一项回顾性队列研究。

Ovarian Endometrioma Negatively Impacts Oocyte Quality and Quantity But Not Pregnancy Outcomes in Women Undergoing IVF/ICSI Treatment: A Retrospective Cohort Study.

机构信息

Reproductive Medicine Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Front Endocrinol (Lausanne). 2021 Nov 22;12:739228. doi: 10.3389/fendo.2021.739228. eCollection 2021.

Abstract

PURPOSE

To determine the impact of ovarian endometrioma on fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes.

METHODS

This retrospective study was conducted using two groups. The endometrioma group consisted of 862 women with infertility who had ovarian endometriomas and underwent their first ovarian stimulation for IVF/ICSI treatment between January 2011 to December 2019 at a public university hospital. A non-endometrioma comparison group, comprising 862 women with other infertility factors, was matched according to maternal age, body mass index (BMI), and infertility duration. Ovarian reserve and response and IVF/ICSI and pregnancy outcomes between the two groups were analyzed. Multivariate logistic regression (MLR) analysis was conducted on the basis of clinical covariates assessed for their association with live birth.

RESULTS

The results showed that significantly lower antral follicle count (AFC), anti-Müllerian hormone (AMH), ovarian sensitivity index (OSI), oocyte maturation and fertilization rates, blastocyst rate, number of oocytes retrieved, and available embryos were found in women with endometrioma compared with the control, respectively (P < 0.05). The cumulative live birth rate patient in women with endometrioma was lower than that of women without endometrioma (39.32% . 46.87%, P = 0.002). In women with endometrioma, those who underwent surgical intervention prior to IVF/ICSI treatment had higher maturation (86.03% . 83.42%, P = 0.003), fertilization (78.16% . 74.93%, P = 0.004), and top-quality embryo rates (42.94% . 39.93%, P = 0.097) but had fewer oocytes retrieved (8.01 ± 5.70 . 9.12 ± 6.69, P = 0.013) than women without surgery. However, live birth rates were comparable between women with endometrioma and women in the control group, regardless of whether they had a prior history of ovarian surgery. MLR analysis showed no correlation between endometrioma and live birth after being adjusted for number of top-quality embryos transferred and stage of embryo transfer.

CONCLUSIONS

The data from this study supported the conclusion that ovarian endometrioma negatively impacts oocyte quality and quantity, but not overall pregnancy outcomes, in women undergoing IVF/ICSI treatment. Endometrioma lowers the cumulative live birth rate by decreasing the number of embryos. Surgical excision of endometrioma prior to IVF/ICSI can partly improve oocyte maturation and fertilization rates but not pregnancy outcomes.

摘要

目的

探讨卵巢子宫内膜异位症对体外受精/卵胞浆内单精子注射(IVF/ICSI)结局的影响。

方法

本回顾性研究采用两组。内异症组 862 例不孕妇女,患有卵巢子宫内膜异位症,于 2011 年 1 月至 2019 年 12 月在一所公立大学医院首次接受 IVF/ICSI 治疗的卵巢刺激。非内异症对照组由 862 例具有其他不孕因素的妇女组成,根据母亲年龄、体重指数(BMI)和不孕持续时间进行匹配。分析两组之间的卵巢储备和反应以及 IVF/ICSI 和妊娠结局。基于临床协变量进行多变量逻辑回归(MLR)分析,以评估其与活产的相关性。

结果

结果显示,与对照组相比,内异症组的窦卵泡计数(AFC)、抗苗勒管激素(AMH)、卵巢敏感指数(OSI)、卵母细胞成熟和受精率、囊胚率、获卵数和可利用胚胎数明显降低(P<0.05)。内异症组患者的累积活产率低于无内异症组(39.32% vs. 46.87%,P=0.002)。在接受 IVF/ICSI 治疗前接受手术干预的内异症患者中,卵母细胞成熟率(86.03% vs. 83.42%,P=0.003)、受精率(78.16% vs. 74.93%,P=0.004)和优质胚胎率(42.94% vs. 39.93%,P=0.097)较高,但获卵数较少(8.01±5.70 vs. 9.12±6.69,P=0.013)。然而,无论是否有卵巢手术史,内异症组与对照组患者的活产率相当。MLR 分析表明,在调整了优质胚胎移植数量和胚胎移植阶段后,内异症与活产之间没有相关性。

结论

本研究数据支持以下结论:卵巢子宫内膜异位症会降低体外受精/卵胞浆内单精子注射治疗患者的卵子质量和数量,但不会降低整体妊娠结局。内异症通过减少胚胎数量降低累积活产率。在 IVF/ICSI 前切除子宫内膜异位症可以部分提高卵母细胞成熟率和受精率,但不能提高妊娠结局。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验